APA (7th ed.) Citation

Brentville, V. A., Metheringham, R. L., Gunn, B., Symonds, P., Daniels, I., Gijon, M., . . . Durrant, L. (2016). Citrullinated vimentin presented on MHC-II in tumor cells is a target for CD4+ T-cell-mediated antitumor immunity. American Association for Cancer Research.

Chicago Style (17th ed.) Citation

Brentville, Victoria A., Rachael L. Metheringham, Barbara Gunn, Peter Symonds, Ian Daniels, Mohamed Gijon, Katherine Cook, Wei Xue, and Lindy Durrant. Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-cell-mediated Antitumor Immunity. American Association for Cancer Research, 2016.

MLA (9th ed.) Citation

Brentville, Victoria A., et al. Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-cell-mediated Antitumor Immunity. American Association for Cancer Research, 2016.